ICO-IO Combinations Summit 2020

Topics

• The specific challenges that come with combining IO therapies with ICIs
• How the response rate to checkpoint combinations can be enhanced to impact every stage of the cancer immunity cycle
• Establishing a New Set of Biological Goals for Checkpoint Inhibitors and IO Combinations
• Navigating the complex ICI-IO landscape – Recent updates and Future Challenges
• Supercharging the Tumor Microenvironment: Lessons from NKTR-214 and Opdivo
• Model Aided Drug Invention Case Study: GITR-mediated T cell dynamics in Mouse Tumor Micro Environment
• Bispecific and Biparatopic Human Heavy Chain Antibodies in Immune Oncology
• A Clinically-Predictive Ex-Vivo Tumor Modelling Platform for Drug Discovery and Development